Aegerion Pharma Inc (AEGR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 58,411 | 72,205 | 68,253 | 90,030 | 97,243 |
| Receivables | 7,843 | 9,077 | 10,821 | 13,557 | 18,221 |
| Inventories | 41,517 | 43,889 | 54,966 | 58,706 | 57,038 |
| TOTAL | $120,778 | $138,363 | $147,139 | $175,938 | $185,263 |
| Non-Current Assets | |||||
| PPE Net | 4,744 | 4,465 | 4,862 | 4,893 | 4,674 |
| Intangibles | 227,779 | 232,825 | 247,471 | 252,517 | 258,619 |
| Other Non-Current Assets | 525 | 225 | 952 | 850 | 4,777 |
| TOTAL | $233,048 | $237,515 | $253,285 | $258,260 | $268,070 |
| Total Assets | $353,826 | $375,878 | $400,424 | $434,198 | $453,333 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 25,000 | 27,841 | 25,000 | 25,000 | 25,000 |
| Accounts payable and accrued liabilities | 9,953 | 5,141 | 9,366 | 10,784 | 10,675 |
| Accrued Expenses | 40,509 | 40,383 | 40,313 | 12,000 | N/A |
| TOTAL | $118,787 | $122,346 | $110,403 | $86,887 | $76,204 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 247,865 | 242,409 | 236,543 | 231,766 | 232,073 |
| TOTAL | $247,865 | $242,409 | $236,543 | $231,766 | $232,073 |
| Total Liabilities | $366,652 | $364,755 | $346,946 | $318,653 | $308,277 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,545 | 29,514 | 29,501 | 29,472 | 28,937 |
| Common Shares | 31 | 31 | 31 | 31 | 30 |
| Retained earnings | -507,733 | -481,167 | -434,358 | -368,804 | -332,205 |
| Other shareholders' equity | -656 | -529 | -299 | 152 | -62 |
| TOTAL | $-12,826 | $11,123 | $53,478 | $115,545 | $145,056 |
| Total Liabilities And Equity | $353,826 | $375,878 | $400,424 | $434,198 | $453,333 |